Posts by Kevin Andrew Raskin, MD
-
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
Researchers from the Orthopaedic Oncology Service found that low albumin, poor nutrition, elevated postoperative glucose and tobacco use are risk factors for wound infection and the need for additional surgery after resection of lower-extremity soft tissue sarcoma.
-
Minimal Clinically Important Differences for Lower Extremity Metastatic Surgery
Orthopaedic oncology researchers at Massachusetts General Hospital worked with Dutch colleagues to conduct the first study to establish minimal clinically important differences on PROMIS questionnaires for patients treated for completed or impending pathological fractures due to lower-extremity metastases.
-
Finding New Approaches to Treat Desmoid Tumor Patients
Surgery for desmoid tumors is only about 50% effective. Multidisciplinary care may be more effective for helping patients find relief.
-
AAOS 2019: A Media Roundup
Health care professionals at this year’s AAOS discussed research findings, novel treatment approaches and innovations on the podium and in the hallways. These conversations generated press across trade publications.
-
First GWAS of Fracture Nonunion Identifies Novel Locus
In the first genome-wide association study of fracture nonunion, researchers at Massachusetts General Hospital have identified multiple loci that warrant investigation in the effort to address this costly outcome.
-
Five Sessions to see at #AAOS2019
The AAOS Annual Meeting is a global exchange for orthopaedic scientists and clinicians. Specialists from Massachusetts General Hospital will present and debate leading research and innovative treatment approaches in orthopaedic care.
-
Analysis of Metastatic Spine Disease Questionnaires
A Mass General study found that metastatic spine patients are best evaluated using PROMIS survey results for function and pain, and SOSG-OQ survey results for quality of life.
Biography
Dr. Kevin Raskin earned a BA from University of California, Santa Barbara, in 1991 and his MD degree from Tel Aviv University in 1997. He completed his internship in general surgery and residency in orthopedic surgery at the Albert Einstein College of Medicine/Montefiore Medical Center. Dr. Raskin completed a fellowship in orthopedic oncology at Massachusetts General Hospital and has been an orthopedic oncology Surgeon at Mass General since 2003. He is a member of the Sarcoma and Connective Tissue Center and Director of the Orthopaedic Oncology Fellowship Program. He is an instructor in orthopedic surgery at Harvard Medical School, where he teaches residents, fellows and medical students both in and out of the operating room.
